Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.340
0.00 (0.00%)
At close: Jul 10, 2026, 4:00 PM EDT
1.320
-0.020 (-1.49%)
After-hours: Jul 10, 2026, 7:56 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.39 million as of July 10, 2026. Its market cap has increased by 35.07% in one year.
Market Cap
5.39M
Enterprise Value
-1.71M
1-Year Change
35.07%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.39M, a decrease of -90.62%. That is a compound annual growth rate of -38.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 5.39M | -12.67% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 6.08M |
| Aptevo Therapeutics | 5.86M |
| Cardio Diagnostics Holdings | 5.74M |
| NuCana | 5.62M |
| Soligenix | 5.62M |
| Liminatus Pharma | 5.61M |
| Processa Pharmaceuticals | 5.57M |
| Enveric Biosciences | 5.30M |